Bazedoxifene/conjugated estrogens explained
Type: | combo |
Component1: | Bazedoxifene |
Class1: | Selective estrogen receptor modulator |
Component2: | Conjugated estrogens |
Class2: | Estrogen |
Tradename: | Duavee, Duavive |
Dailymedid: | Duavee |
Pregnancy Au: | D |
Pregnancy Au Comment: | [1] |
Routes Of Administration: | By mouth |
Atc Prefix: | G03 |
Atc Suffix: | CC07 |
Legal Us: | Rx-only |
Legal Us Comment: | [2] |
Legal Eu: | Rx-only |
Legal Status: | Rx-only |
Cas Number: | 1422348-02-4 |
Chemspiderid: | None |
Kegg: | D10579 |
Bazedoxifene/conjugated estrogens, sold under the brand name Duavee in the US and Duavive in the EU, is a fixed-dose combination medication for the treatment of menopause symptoms and postmenopausal osteoporosis.[3] [4] [5] It contains the selective estrogen receptor modulator bazedoxifene and conjugated estrogens. It is taken by mouth.
The combination was approved for medical use in the United States in October 2013,[6] and in the European Union in December 2014.[7]
See also
External links
Notes and References
- Web site: Bazedoxifene / conjugated estrogens (Duavee) Use During Pregnancy . Drugs.com . 16 February 2019 . 23 June 2020.
- Web site: Duavee- conjugated estrogens/bazedoxifene tablet, film coated . DailyMed . 16 July 2021 . 21 February 2022.
- Web site: Duavee. Generic Name: conjugated estrogens and bazedoxifene tablets . rxlist.com.
- Palacios S, Mejía Ríos A . Bazedoxifene/conjugated estrogens combination for the treatment of the vasomotor symptoms associated with menopause and for prevention of osteoporosis in postmenopausal women . Drugs of Today . 51 . 2 . 107–16 . February 2015 . 25756066 . 10.1358/dot.2015.51.2.2281023 .
- Lello S, Capozzi A, Scambia G . The Tissue-Selective Estrogen Complex (Bazedoxifene/Conjugated Estrogens) for the Treatment of Menopause . International Journal of Endocrinology . 2017 . 5064725 . 2017 . 29358948 . 5735652 . 10.1155/2017/5064725 . free .
- Web site: Drug Approval Package: Duavee (conjugated estrogens and bazedoxifene) NDA #022247 . U.S. Food and Drug Administration (FDA) . 7 October 2013 . 23 June 2020.
- Web site: Duavive EPAR . 10 June 2020. European Medicines Agency (EMA). 17 September 2018 .